Skip to Content

Workers’ Compensation Board

Search menu

Subject Number 046-1118 Temporary Suspension of Dr. Robert B. Litman

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 129600-3W

November 16, 2018

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Litman’s authorization to treat injured workers within the New York State workers’ compensation system effective November 8, 2018. Dr. Litman's last known business address is:

P.O. Box 775
Lincoln, California 95648-0775.

The Chair’s designee’s investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Commissioner’s Order of Summary Action # 18-238, wherein Dr. Litman shall not practice medicine in the State of New York, or practice in any setting under the authority of his New York license. This Order is based on a California Board Order whereby Dr. Litman must surrender his California license, based on allegations he suffers from a neurocognitive disorder that makes him unable to safely practice medicine, and that he ordered large quantities of controlled substances for his own personal use.

Therefore, the Chair believes that Dr. Litman may be guilty of misconduct as described in a violation of Education Law §6530(8), and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Litman is prohibited from rendering treatment and care to injured workers, or to conduct reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a), while his authorization is temporarily suspended. Reports submitted by Dr. Litman for services rendered prior to November 8, 2018, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Litman for services rendered prior to November 8, 2018, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Clarissa M. Rodriguez
Chair